Shots:

• The US FDA is upgrading the Purple Book by changing it from the current list format to a searchable online database. The FDA has released the first phase that contains information on FDA-licensed biosimilar and interchangeable products along with their reference products
• The further release of phases will expand the number of FDA-licensed biological products included in the Purple Book online database until the final release- which will include information about all FDA-licensed biological products
• The expansion & digitization of the Purple Book will make information of FDA-licensed biological products more accessible & transparent for patients- industry users and other stakeholders

Click here- Click here ­to­ read full press release/ article | Ref: US FDA | Image: US FDA